Case Comprehensive Cancer Center

Case Comprehensive Cancer Center (Case CCC) has been recognized by the National Cancer Institute (NCI) with a merit award of outstanding 19 months after transitioning to a new director. The NCI site visit committee noted institutional commitment, leadership, exceptional efforts in cancer research...

Case Comprehensive Cancer Center (Case CCC) has been recognized by the National Cancer Institute (NCI) with a merit award of outstanding 19 months after transitioning to a new director. The NCI site visit committee noted institutional commitment, leadership, exceptional efforts in cancer research...

Finding offers potential new target for treatment

Breast cancer is the leading cause of cancer-related deaths among women globally. Women in Case CCC's 15-county catchment area have higher incidence and mortality rates than in all of Ohio and the United States, particularly those of non-Hispanic Black descent. Sichun Yang, PhD, a Case CCC Molecula...

Johnie Rose, MD, PhD, Director of Case CCC's Population Cancer Analytics Shared Resource, contributed to an article in the online publication, Medium. His sobering information about the factors that determine who gets cancer and who doesn’t has more to do with humans than one might think. He said, ...

The Case Comprehensive Cancer Center (Case CCC) community gathered for the Ohio Cancer Research (OCR) Star Award Gala on Nov. 13, 2024, to celebrate two of Case CCC's biggest stars—Director Gary Schwartz, MD, and long-time member Sanford "Sandy" Markowitz, MD, PhD. OCR opens doors that save lives ...

Bianca Islam, MD, PhD, faces no small task as an Ambassador for the American Cancer Society's (ACS) Voices of BLACK Women Project. Her job is to help encourage 100,000 Black women, aged 25-55 who've never had a cancer diagnosis, to participate in a 30-year, multi-phase, longitudinal study with no im...

Two representatives from Alvin H. Schmaier’s lab at Case Comprehensive Cancer Center were selected to give oral presentations at the 66th American Society of Hematology Annual Meeting. Rodrigo Silva-Aguiar, a postdoctoral fellow, and Alessandro Pinheiro, a senior research associate, will talk about...

Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). Alzheimer’s disease is a brain disorder tha...

Case CCC Immune Oncology Program member, Amar Desai, PhD, has been awarded $100,000 in funding for one year from the Innovative Science Accelerator Program (ISAC) for his project Antihistamines to prevent age-associated hematopoietic decline. He aims to demonstrate that repurposing a well tolerated ...